跳至主要内容
临床试验/NCT05723302
NCT05723302已完成不适用

The Effect of Resistant Proprioceptive Neuromuscular Facilitation Exercises on Respiratory Muscle Strength in Chronic Obstructive Pulmonary Diseases

Istanbul Medipol University Hospital4 个研究点 分布在 2 个国家目标入组 31 人开始时间: 2017年1月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
31
试验地点
4
主要终点
HADS

研究概览

简要总结

To investigate the effects of resistant proprioceptive neuromuscular facilitation exercises on physical fitness, respiratory muscle strength, walking distance and quality of life in chronic obstructive pulmonary patients.

详细描述

The study was carried out between January 2017 and January 2019, with patients followed up with the diagnosis of COPD in Çanakkale Mehmet Akif Ersoy State Hospital and Çanakkale Onsekiz Mart University Medical Faculty Hospital, Department of Chest Diseases. It was approved by Istanbul Medipol University Non-Interventional Clinical Research Ethics Committee (Date: 30.12.2016, Decision No. 573) and was done in accordance with the Declaration of Helsinki. All participants were informed about the purpose of the study, the total duration of treatment and the applications to be made, and a consent form was signed. The study was conducted as a prospective and randomized controlled study, and inclusion and exclusion criteria were determined.

Thirty-five patients diagnosed with COPD were referred to the study, four patients were excluded because they did not meet the inclusion criteria, and the study was conducted with a total of 31 participants.

The 31 patients included in the study were randomized after their initial evaluation and divided into two groups as experimental and control groups. Patients meeting the inclusion criteria were divided into 2 groups. Randomized by ordering by date of application.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
38 Years 至 67 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • To be diagnosed with stage 1, stage 2 and stage 3 COPD according to GOLD (Global Initiative for Obstructive Lung Diseases) criteria
  • Having FEV1/FVC <70% according to pulmonary function test
  • Being clinically stable
  • Being over 18 years old
  • Volunteer to participate in the program

排除标准

  • Having a COPD exacerbation in the last 8 weeks
  • To have participated in a regular exercise training program in the last 1 year
  • Having a musculoskeletal disease and neuromuscular disease that may prevent exercise
  • Inability to cooperate for pulmonary function test and respiratory muscle strength measurement
  • Being on long-term oxygen therapy

结局指标

主要结局

HADS

时间窗: 10 minutes

Hospital Anxiety Depression Scale

次要结局

  • SGRQ(15 minutes)

研究者

发起方
Istanbul Medipol University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

sevda vurur

Student

Istanbul Medipol University Hospital

研究点 (4)

Loading locations...

相似试验